Table 3.
Laterality of luminal A breast cancer patients and their treatment profiles.
Characteristic | Total IBrC | Left IBrC | Right IBrC | p-Values | LRR | |||
---|---|---|---|---|---|---|---|---|
n | % | n | % | n | % | |||
Surgery | ||||||||
BCS | 43 | 70 | 18 | 75 | 25 | 68 | 0.5341 | 0.72 |
MRM | 18 | 30 | 6 | 25 | 12 | 32 | 0.5 | |
Radiotherapy | ||||||||
No | 11 | 18 | 3 | 12.50 | 8 | 22 | 0.3653 | 0.37 |
Yes | 50 | 82 | 21 | 87.50 | 29 | 78 | 0.72 | |
Brachytherapy | ||||||||
No | 32 | 52 | 14 | 58 | 18 | 49 | 0.4594 | 0.77 |
Yes | 29 | 48 | 10 | 42 | 19 | 51 | 0.52 | |
Chemotherapy | ||||||||
No | 47 | 77 | 22 | 92 | 25 | 68 | 0.0288 | 0.88 |
Yes | 14 | 23 | 2 | 8 | 12 | 32 | 0.16 | |
Hormonal therapy | ||||||||
No | 4 | 7 | 0 | 0 | 4 | 11 | 0.0957 | 0 |
Yes | 57 | 93 | 24 | 100 | 33 | 89 | 0.72 |
IBrC—invasive breast carcinoma, LRR—left-to-right ratio, BCS—breast-conserving surgery, MRM—modified radical mastectomy; a significant difference is denoted by bold p-values; underlined p-values represent closeness to statistical significance.